✦ LIBER ✦

472 A phase I study of IMGN388, an antibody drug conjugate targeting av integrin, in patients with solid tumors

✍ Scribed by J. Bendell; K. Moore; A. Qin; D. Johnson; J. Schindler; K. Papadopoulos; A.W. Tolcher

Book ID: 119603155
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 47 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)72179-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Safety and Pharmacokinetic Study

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

✍ Gerber, D. E.; Stopeck, A. T.; Wong, L.; Rosen, L. S.; Thorpe, P. E.; Shan, J. S 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 346 KB

166 A phase I dose-escalation study of a

166 A phase I dose-escalation study of anti-a5β1 integrin monoclonal antibody (M200) in patients with refractory solid tumors

✍ A. Ricart; G. Liu; A. Tolcher; G. Schwartz; J. Harris; R. Stagg; E. Rowinsky; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Phase I/II Study of the Antibody-Drug Co

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

✍ Ott, P. A.; Hamid, O.; Pavlick, A. C.; Kluger, H.; Kim, K. B.; Boasberg, P. D.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 254 KB

29 A First-in-Human Phase I Monotherapy

29 A First-in-Human Phase I Monotherapy Study of RG7212 (R), a Novel Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Solid Tumors

✍ Lassen, U.; Schellens, J.H.M.; Siu, L.L.; Jonker, D.J.; Sorensen, M.; Jarutat, T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A phase I study of the human monoclonal

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

404 Phase I study of MEDI-575, a fully h

404 Phase I study of MEDI-575, a fully human monoclonal antibody targeting PDGFR-alpha in subjects with advanced solid tumors

✍ R. Lechleider; C. Becerra; M. Liang; R. Narwal; L. Shi; P. Conkling; M. Galsky; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB